Bionik Laboratories Corp. (BNKL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.77 Million USD | -8.98% |
| 2022 | -9.48 Million USD | 27.36% |
| 2021 | -13.02 Million USD | 44.47% |
| 2020 | -24.63 Million USD | -56.51% |
| 2019 | -6.94 Million USD | 27.88% |
| 2018 | -9.72 Million USD | -31.42% |
| 2017 | -7.39 Million USD | -11.49% |
| 2016 | -6.56 Million USD | -22148.43% |
| 2015 | -29.52 Thousand USD | -125.25% |
| 2014 | -13.1 Thousand USD | -45.56% |
| 2013 | -9006.00 USD | -101.07% |
| 2012 | -4479.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | - USD | 100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q2 | -1.09 Million USD | 19.62% |
| 2023 FY | - USD | -8.98% |
| 2023 Q1 | -1.36 Million USD | 6.09% |
| 2023 Q4 | -1.28 Million USD | -24.98% |
| 2023 Q3 | -1.02 Million USD | 6.7% |
| 2022 Q4 | -1.45 Million USD | 3.12% |
| 2022 Q3 | -1.5 Million USD | -48.43% |
| 2022 Q2 | -1.01 Million USD | -217.02% |
| 2022 FY | - USD | 27.36% |
| 2022 Q1 | -319.5 Thousand USD | 64.31% |
| 2021 Q4 | -895.16 Thousand USD | 45.79% |
| 2021 Q1 | -1.86 Million USD | 27.24% |
| 2021 Q2 | -1.43 Million USD | 22.99% |
| 2021 FY | - USD | 44.47% |
| 2021 Q3 | -1.65 Million USD | -14.78% |
| 2020 Q2 | -3.28 Million USD | -57.02% |
| 2020 Q3 | -2.92 Million USD | 10.81% |
| 2020 Q4 | -2.56 Million USD | 12.26% |
| 2020 FY | - USD | -56.51% |
| 2020 Q1 | -2.08 Million USD | 12.13% |
| 2019 Q3 | -2.02 Million USD | -3.84% |
| 2019 FY | - USD | 27.88% |
| 2019 Q1 | -578.93 Thousand USD | 77.35% |
| 2019 Q2 | -1.95 Million USD | -237.67% |
| 2019 Q4 | -2.37 Million USD | -17.16% |
| 2018 Q2 | -3.42 Million USD | -75.48% |
| 2018 Q4 | -2.55 Million USD | -37.35% |
| 2018 Q1 | -1.95 Million USD | 21.64% |
| 2018 FY | - USD | -31.42% |
| 2018 Q3 | -1.86 Million USD | 45.67% |
| 2017 FY | - USD | -11.49% |
| 2017 Q2 | -3.9 Million USD | -103.78% |
| 2017 Q3 | -1.54 Million USD | 60.49% |
| 2017 Q4 | -2.49 Million USD | -61.33% |
| 2017 Q1 | -1.91 Million USD | 1.19% |
| 2016 Q1 | -2.41 Million USD | -95.5% |
| 2016 Q4 | -1.94 Million USD | -90.59% |
| 2016 Q3 | -1.01 Million USD | 12.78% |
| 2016 Q2 | -1.16 Million USD | 51.7% |
| 2016 FY | - USD | -22148.43% |
| 2015 Q1 | -3567.00 USD | -288.99% |
| 2015 FY | - USD | -125.25% |
| 2015 Q4 | -1.23 Million USD | -5124.39% |
| 2015 Q3 | -23.66 Thousand USD | -1617.42% |
| 2015 Q2 | -1378.00 USD | 61.37% |
| 2014 Q1 | -5820.00 USD | -101.94% |
| 2014 FY | - USD | -45.56% |
| 2014 Q4 | -917.00 USD | 65.16% |
| 2014 Q3 | -2632.00 USD | -48.28% |
| 2014 Q2 | -1775.00 USD | 69.5% |
| 2013 Q2 | 1141.00 USD | -69.98% |
| 2013 Q3 | -12.11 Thousand USD | -1162.14% |
| 2013 Q4 | -2882.00 USD | 76.22% |
| 2013 FY | - USD | -101.07% |
| 2013 Q1 | 3801.00 USD | 307.82% |
| 2012 Q1 | - USD | 100.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | -1829.00 USD | 60.74% |
| 2012 Q3 | -4659.00 USD | -437.61% |
| 2012 Q2 | 1380.00 USD | 0.0% |
| 2011 Q4 | -1200.00 USD | 0.0% |
| 2011 Q2 | -4629.00 USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 56.519% |
| Arem Pacific Corporation | 36.71 Thousand USD | 13107.523% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | -4129.625% |
| BioCorRx Inc. | -2.68 Million USD | -77.938% |
| Banyan Corp. | 583.94 Thousand USD | 917.84% |
| Clearday, Inc. | -7.53 Million USD | 36.631% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | 37198.672% |
| Quantum Medical Transport, Inc. | - USD | Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | -338.832% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | -116.116% |
| Selectis Health, Inc. | -7.29 Million USD | 34.527% |
| Ethema Health Corporation | 2.07 Million USD | 330.469% |
| HealthLynked Corp. | -2.75 Million USD | -73.643% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | -79.918% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | 16655.89% |
| Comjoyful International Company | 167.89 Thousand USD | 2944.464% |
| Medical Facilities Corporation | 77.94 Million USD | 106.127% |
| MedSmart Group Inc. | 47.8 Thousand USD | 10089.148% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | -666.161% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 580.229% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | -2267.378% |
| PAO Group, Inc. | 292.96 Thousand USD | 1730.142% |
| Primemd Inc. | 3.42 Million USD | 239.358% |
| Raffles Medical Group Ltd | 100.7 Million USD | 104.743% |
| Ryman Healthcare Limited | -54.51 Million USD | 91.24% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -112720.978% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | -65.007% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | -759.703% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | -9646.351% |
| Veltex Corporation | -938.45 Thousand USD | -408.89% |
| World Financial Holding Group | -28.43 Thousand USD | -16698.143% |
| Xcelerate Inc. | -2.53 Million USD | -88.143% |